Skip to main content

Pediatric Multiple Sclerosis

<p>Multiple sclerosis (MS) is thought to be an autoimmune disease that attacks the central nervous system (CNS).&nbsp;It affects about 1 in 1,000 people.</p>

In the Journals: Nirsevimab

Jan 18, 2024

Find out about the results of a prospective, placebo-controlled trial in 8,058 healthy infants that served as the basis for licensure of nirsevimab.

Jump back to top